A. Horvath et al., A HEMAGGLUTININ-BASED MULTIPEPTIDE CONSTRUCT ELICITS ENHANCED PROTECTIVE IMMUNE-RESPONSE IN MICE AGAINST INFLUENZA-A VIRUS-INFECTION, Immunology letters, 60(2-3), 1998, pp. 127-136
Multipeptide constructs, comprising adjacent sequences of the 317-341
intersubunit region of immature influenza A hemagglutinin (H1N1), were
designed and the functional properties of these branched peptides wer
e compared to that of the corresponding linear peptides. In vivo studi
es revealed that the immunogenicity of the peptides was dependent on t
he presence of the hydrophobic fusion peptide (comprised in FP3), enco
mpassing the N-terminal 1-13 sequence of the HA2 subunit. Antibody and
T cell recognition, however, was directed against the 317-329 HA1 seq
uence, comprised in the P4 peptide. Multiple copies of P4, covalently
linked by branched lysine residues, significantly enhanced the efficie
ncy of antibody binding and the capacity of peptides to elicit B- and
T-cell responses. A fraction of peptide induced antibodies reacted wit
h immature or with proteolitically cleaved hemagglutinin (HA) molecule
s pretreated at low pH. Immunization with a multipeptide construct, (P
4)(4)-FP3, not only resulted in elevated antibody and T cell responses
but conferred enhanced protection against lethal A/PR/8/34 (H1N1) inf
ection as compared to its subunit peptides. The beneficial functional
properties of this artificial peptide antigen may be acquired by multi
ple properties including: (i) stabilized peptide conformation which pr
omotes strong, polyvalent binding to both antibodies and MHC class II
molecules; (ii) appropriate P4 conformation for antibody recognition s
tabilized by the covalently coupled fusion peptide, resulting in the p
roduction of virus cross reactive antibodies which inhibit the fusion
activity of the virus; (iii) activation of peptide specific B cells wh
ich potentiate antigen presentation and peptide specific T cell respon
ses; and (iv) generation of helper T cells which secrete lymphokines a
ctive in the resolution of infection. (C) 1998 Elsevier Science B.V. A
ll rights reserved.